Technology
Live Price
Offline$25.18
+0.00% today
Window Change
+28.40%
Window
Jun 23, 2025 → Dec 5, 2025
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 117 bars · Jun 23, 2025 → Dec 5, 2025
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Babcock & Wilcox Enterprises, I (BWSN) is a Technology stock with a market cap of $2.80B. The stock last traded around $25.18 and up 28.4% across the available one-year price window (Jun 23, 2025 → Dec 5, 2025). Baseline metrics include revenue growth of -18.1%, EPS growth of +41.5%, a dividend yield of 0.0%. What stands out right now is revenue -18.1%, EPS +41.5%, free cash flow +34.0% with operating margin 5.2% and ROIC 7.7%. Valuation is more restrained than many high-expectation growth names at price/sales 2.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BWSN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BWSN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BWSN Max Drawdown
-5.14%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BWSN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$710.9M
+16.6% YoY
FY Net Income
$30.9M
+235.1% YoY
Free Cash Flow
-$117.9M
-168.7% YoY
Revenue Growth
-18.1%
EPS Growth
+41.5%
Gross Margin
25.5%
Net Margin
-5.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 588M | 717M | 727M | 609M | 711M |
| Gross Profit | 144M | 177M | 177M | 145M | 175M |
| Operating Income | 23M | 25M | 17M | -1M | 19M |
| EBITDA | 33M | 2M | -2M | 59M | 79M |
| Net Income | -36M | -60M | -197M | -23M | 31M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 90M | 23M | 40M | 76M | 225M |
| Total Assets | 663M | 727M | 776M | 942M | 913M |
| Total Liabilities | 795M | 1.0B | 976M | 944M | 855M |
| Shareholder Equity | -132M | -284M | -201M | -3M | 33M |
| Total Debt | 369M | 538M | 434M | 410M | 403M |
| Net Debt | 279M | 515M | 394M | 334M | 178M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
111M
-262.9% YoY
Capital Expenditures
7M
+49.5% YoY
Free Cash Flow
118M
-168.7% YoY
Key ratios
Gross Margin
25.5%
Operating Margin
5.2%
Net Margin
-5.7%
ROE
14.8%
Debt / Equity
-2.80x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.